![]() ![]() Studies have found that GLP-1R is widely distributed on pancreatic and other tissues and has multiple biological effects, such as reducing neuroinflammation, promoting nerve growth, improving heart function, suppressing appetite, delaying gastric emptying, regulating blood lipid metabolism and reducing fat deposition. GLP-1 receptor agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their attributes such as body weight loss, protection of islet β cells, promotion of islet β cell proliferation and minimal side effects. Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. 2Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, China.1Department of Pharmacology, Shanxi Medical University, Taiyuan, China. ![]() Xin Zhao 1‡ Minghe Wang 1‡ Zhitong Wen 1 Zhihong Lu 1 Lijuan Cui 1 Chao Fu 1 Huan Xue 1 Yunfeng Liu 2*§ Yi Zhang 1*†§ Effects of Glucagon Like Peptide-1 Receptor Agonists on Tumor Diseases.Effects on Non-Alcoholic Fatty Liver Disease.Effects of Glucagon Like Peptide-1 Receptor Agonists on Endocrine Metabolism.Effects of Glucagon Like Peptide-1 Receptor Agonists on the Cardiovascular System.Effects of Glucagon Like Peptide-1 Receptor Agonists on the Neurological System.Brief Introduction and Physiological Function of Glucagon Like Peptide-1 Receptor Agonists.Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Kuwait University, Kuwait TABLE OF CONTENTS ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |